investors.amedica.com/...ilingid=1269026-15-57&CIK=1269026
A "Special Meeting" of Stockholders of AMDA (the Company) on 11/03/15. Stockholders approved:
1: Issuance of common stock of the Company, par value $0.01 per share (Common Stock), representing more than 19.99% of the outstanding Common Stock or voting power of the Company in exchange for an aggregate of gross proceeds of approximately $10 million pursuant to the exercise of the Series B and Series C Warrants issued in connection with that certain securities purchase agreement entered into with certain investors named therein, dated 09/08/15, and any Series D Warrants issued in relation to the Series B or Series C Warrants.
2: Amendment to the Companys Restated Certificate of Incorporation to effectuate a reverse stock split of the Companys issued and outstanding shares of Common Stock at a ratio of between 1-for-2 and 1-for-15, inclusive, which ratio will be selected at the sole discretion of our Board of Directors at any whole number in the above range, with any fractional shares that would otherwise be issued as a result of the reverse stock split being rounded up to the nearest whole share (the Reverse Stock Split); provided, that our Board of Directors may abandon the Reverse Stock Split in its sole discretion.
3: Ratify the appointment of Mantyla McReynolds LLC as independent registered public accounting firm for the year ending.
4: One or more adjournments of the special meeting, if necessary or appropriate, to solicit additional proxies if there are insufficient votes at the time of the meeting to adopt one or more of the foregoing Proposals.
Zurück
